Insider Transactions
| Date | Filer | Filing | Type | Shares Traded | Total Held |
|---|---|---|---|---|---|
| Jul 26, 2022 |
President & COO
Trans History: 268
|
Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 158,116 | 158,116 |
| Jul 26, 2022 |
Chief Financial Officer
Trans History: 14
|
Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 158,264 | 882,396 |
| Jul 26, 2022 |
Chief Financial Officer
Trans History: 14
|
Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 106,617 | 106,617 |
| Jul 26, 2022 |
VP-General Counsel & Secretary
Trans History: 18
|
Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 76,818 | 389,647 |
| Jul 26, 2022 |
VP-General Counsel & Secretary
Trans History: 18
|
Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 51,750 | 51,750 |
| Jul 07, 2022 |
Director
Trans History: 9
|
Form 4 | Open market or private sale of non-derivative or derivative security | 17,803 | 137,639 |
| Jul 07, 2022 |
Chief Commercial Officer
Trans History: 19
|
Form 4 | Open market or private sale of non-derivative or derivative security | 98,526 | 773,177 |
| Jul 07, 2022 |
Director, Chief Executive Officer
Trans History: 216
|
Form 4 | Open market or private sale of non-derivative or derivative security | 249,790 | 2,018,127 |
| Jul 07, 2022 |
Director
Trans History: 125
|
Form 4 | Open market or private sale of non-derivative or derivative security | 15,260 | 164,222 |
| Jul 07, 2022 |
President & COO
Trans History: 268
|
Form 4 | Open market or private sale of non-derivative or derivative security | 79,145 | 881,305 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.